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Principles: This retrospective study analyzes
the long-term results of endoscopic and surgical
treatment of vesico-ureteral reflux in children.
Methods: A cohort of 130 patients, 67 girls and
63 boys with a mean age of 30 months were
treated either by endoscopic subureteral collagen
injection (SCIN) in 92 and by Cohen reimplanta-
tion surgery in 123 refluxing ureteral units. Mean
follow-up was 4.2 years varying from 1 to 8.7
years. Reflux recurrence, urinary tract infection
(UTI) and renal function were evaluated. 
Results: After SCIN reflux was absent in 64%
at 6 months. 20% of the initially 92 refluxing
ureters were injected twice. After one or two in-
jections reflux was absent in 71%. In 21% recur-
rent reflux was of grade I or II, not requiring fur-
ther treatment. UTI was observed in 27%. After
Cohen ureteral reimplantation reflux was absent
in 96% at 6 months. UTI was observed in 23%.
Renal function at diagnosis and follow-up was
compared in children with bilateral grade III re-
flux only. In patients treated with SCIN it was
normal in 77% preoperatively and in 90% at fol-
low-up. In patients treated by open surgery it was
normal in 47% preoperatively and in 76% at fol-
low-up. 
Conclusion: For high-grade vesico-ureteral
 reflux re-implantation surgery remains the gold
standard. SCIN is indicated for low and medium
grade reflux. Recurrent bacteriuria was observed
more often after SCIN and pyelonephritis more
often after open surgery. The renal function
seems to be preserved with both techniques.
Key words: vesico-ureteral reflux; endoscopy; colla-
gen; reimplantation; radioisotope renography
Summary
Vesico-ureteral reflux (VUR) is characterized
by retrograde flow of urine from the bladder into
the upper urinary tract. It affects approximately
1% of children and in the postnatal period is fre-
quently associated with urinary tract infections
(UTI), which lead to diagnostic procedures and
final diagnosis [1–2]. Prenatal findings of hy-
dronephrosis and mega-ureter should also initiate
postnatal diagnostic procedures to exclude or
confirm reflux. Untreated reflux may be responsi-
ble for recurrent upper UTI, renal scarring and in
the long-term for renal insufficiency and hyper-
tension [3–4]. The primary aim of reflux therapy
is the prevention of parenchymatous damage due
to ascending UTI. This therapy can be either
medical or surgical. Medical therapy with long-
term antibiotic prophylaxis is based on the princi-
ple that reflux often resolves with time. Antibiotic
prophylaxis can be compromised by lack of com-
pliance, break-through infections due to antibi-
otic resistance and rarely by side effects of the
therapy. Spontaneous resolution of VUR de-
creases with increasing grade of reflux [5]. Inter-
ventional therapy cures reflux immediately and
therefore prevents ascending infection. It is done
either by surgical ureteral reimplantation, apply-
ing the techniques of Cohen [6], Leadbetter-Poli-
tano [7], Lich-Gregoir [8] or Glenn-Anderson, or
by endoscopic subureteral injection of a bulking
agent. All techniques are based on the principle of
elongation of the intravesical submucosal tunnel
of the ureter. The endoscopic procedure has be-
come more common, because patients prefer to
undergo less painful outpatient surgery without
scaring. Non-biological, but biocompatible bulk-
ing agents such as polytetrafluorethylene (Teflon)
or silicone have been injected. Persistence in the
body, local granuloma formation, distant migra-
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tion [9–10] are disadvantages of these agents.
Nowadays degradable biological materials such as
bovine collagen [11] or hyaluronic acid (Deflux®)
[12] are predominantly used, although they are
less effective in curing reflux than non-degradable
materials. In the use of collagen and Deflux® no
particle migration has been observed, however
collagen could theoretically provoke anaphylactic
reaction, which is unlikely in the use of Deflux®
[13].
In this study we retrospectively analyzed our
long-term experience of Cohen re-implantation
versus endoscopic subureteral collagen injection
(SCIN) [14] in regard to reflux recurrences, UTI
and renal function.
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Material and methods
Between 1992 and 1999, 130 children, 67 girls and
63 boys with a total of 215 refluxing ureteral units were
treated by endoscopic subureteral collagen injection
(SCIN) or by ureteral reimplantation according to
Cohen. 
Of the 215 refluxing ureteral units, 92 were treated
by SCIN in 56 children and 123 by Cohen reimplanta-
tion in 74 cases. Reflux was diagnosed by standard voiding
cystourethrography (VCUG) and graded according to
the International Reflux Study (IRS) in children [15]. The
repartition of initial reflux according to its grade and to
the respective method of treatment is demonstrated in
figure 1. Ureters showing grade I or II were only treated
if the contralateral ureter had reflux of a higher grade as
seen in 35 patients. In a further 8 cases low-grade reflux
was treated because of break-through infections despite
antibiotic prophylaxis or because deteriorating renal
function was observed. Mean age at the first operation
was 2.6 years, (2 months to 11.8 years) and the average
follow-up was 50 months (12 to 104 months). 
SCIN was performed under general anaesthesia with
the patient placed in lithotomy position using a 9.5 or
11.5Ch cystoscope, according to the previously described
method [16]. The average collagen injected per refluxing
units was 2.7mls ranging from 0.4 to 4.5mls. Anti-reflux
surgery consisted in trans-trigonal ureteroneocystostomy
according to Cohen [6].
Postoperatively antibiotic treatment was given for 
10 days followed by prophylaxis until VCUG proved the
absence of reflux at the 6-month control. In addition
 patients treated with SCIN underwent a second VCUG
at 12 months to exclude late recurrence. Ultrasonography
was performed at each control.
I-123-hippuran renography was performed at diag-
nosis and 2 to 8 years after injection or surgery. Absolute
individual renal function was measured by an accumula-
tion index (AI) defined as the percentage of injected dose
(% ID) extracted by each kidney 30 to 90 seconds after
heart-peak activity injection. Normal AI (mean±SD) is
9±2 %ID in children aged >1 year, 8±2 %ID in neonates
and infants [17–18]. 
Proven upper UTI led to further ultrasonography
and VCUG. Apart from radiological work-up, medical
history taking and clinical examination was performed at
up to 5 years after treatment. Bacteriuria, seen in lower
UTI, was characterized by ≥105 bacteria/ml, with temper-
ature lower than 38.5 °C. Pyelonephritis, seen in upper
UTI, was characterized by ≥105 bacteria/ml with temper-
ature higher than 38.5 °C and bacterial monoculture. In
patients with a history of urinary tract symptoms with
 urgency, pain at micturition without positive bacterial
culture we considered a dysuria syndrome likely to be
present.
Results
The initial 215 refluxing ureters treated either
by endoscopic subureteral collagen injection
(SCIN) (92 ureters) or by Cohen’s reimplantation
surgery (123 ureters), according to their grade, are
shown in figure 1.
Voiding cystourethrography performed im-
mediately after SCIN showed the absence of
 reflux in all cases. These patients were followed 
up with a further voiding cystourethrography at 
6 months. Reflux was absent in 61 of the 92
ureters (64%) treated by SCIN after one injec-
tion. Early recurrence of reflux after one injection
is shown in figure 2 and its repartition in table 1.
Of the 31 ureters with recurrent reflux at 6
months, 18 ureters in 14 patients (20% of the total
of 92 ureters) required a second collagen injec-
tion. The remaining refluxing ureters showed
 reflux of grade I or II not requiring any further
 inter ventional treatment. In another 6 ureters in 
3 patients, we found a late recurrence after one
year that required a second collagen injection. Of
all 24 re-injected ureters only 2 ureters in one pa-
tient were ultimately reimplanted for persistence
of grade III reflux bilaterally. In the remaining
ureters absence of reflux was noticed in 15 and
 recurrent reflux of grade I and II, not needing any
further interventional treatment, in 7 ureters. In
Figure 1
Repartition of initially
refluxing ureters
 according to grade 
of reflux and to type
of treatment: SCIN
endoscopic sub -
ureteral collagen
 injection (n = 92) 
or Cohen’s reimplan-
tation surgery 
(n = 123).
Refluxing 
ureters
Grade of reflux
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the observation period between 12 months and
104 months (1 to 8.7 years) the overall absence of
reflux after one or two injections was noted in 65
(71%) of the initial 92 refluxing ureters, In addi-
tion 19 ureters (21%) showed recurrent reflux of
grade I or II not requiring further interventional
treatment. In 6 ureters (6%) presenting with
higher reflux recurrences antibiotic prophylaxis
was re-administered and a further 2 ureters (2%)
were operated upon with reimplantation surgery.
At 6 months reflux was absent in 118 of the
123 ureters (96%) treated by Cohen reimplanta-
tion. Of the 5 ureters with recurrent reflux at 6
months, 3 ureters in 2 patients (2.5% of the total
of 123 ureters) required further interventional
treatment, two by SCIN and one by reimplanta-
tion surgery. The remaining two were of low
grade reflux and therefore did not require any
treatment. One of 118 ureters where reflux was
absent developed distal ureteral stenosis needing
resection and secondary reimplantation.
Postoperative UTI were reported in 15 pa-
tients (27%) treated with collagen injection, and
in 17 (23%) treated with Cohen reimplantation.
In these patients pyelonephritis and bacteriuria
were differentiated. Their appearance in relation
to the following successful and non-successful
treatment was analyzed and is shown in table 2.
Postoperative dysuria was observed in 5 patients
treated with SCIN and in 3 after Cohen reim-
plantation. 
All patients had I-123-OIH-renography at
 diagnosis and follow-up. We analyzed separate
renal function in subgroups of 39 children with
bilateral grade III matched for the age at diagno-
sis, surgery and follow-up. High grade reflux, im-
paired renal function and break-through infection
were indications per se to perform open reflux
surgery. However, in patients with reflux grade III
without impaired function and infection, collagen
injection was preferably used.  20 children were
treated with SCIN, 19 by Cohen reimplantation.
Initial function was decreased in 9 (23%) of 40
kidneys selected for SCIN, in 20 (53%) of 38
 selected for the Cohen operation. It remained
 decreased at follow-up in 7 (18%) and 9 (24%),
respectively. Preoperative AI was 9.8±1.7 %ID 
in the SCIN group, 8.0±3.2 %ID in the Cohen
group At follow-up, AI increased in both groups:
11.4±2.2 %ID and 10.4±3.4 %ID, respectively. 20
children (8 SCIN, 12 Cohen) had surgery before
1 year of age, 19 children after this age (12 SCIN,
7 Cohen). In the younger infants, AI increased
from 9.5±1.7 %ID in the SCIN group, and from
7.7±3.0 %ID in the Cohen group. One kidney
treated with SCIN had an initially decreased
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Refluxing 
ureters
Figure 2
Repartition of recur-
rent refluxing ureters
after treatment with
SCIN endoscopic
subureteral collagen
injection (n = 92) 
or  Cohen’s reimplan-
tation surgery 
(n = 123), according
to grade of initial 
reflux.
Treatment Grade of Number of initially Recurrent reflux according to its grade
initial reflux refluxing ureters I II III IV V Total
SCIN I 7 0 0 0 0 0 0
II 20 0 7 2 0 0 9
III 57 4 11 4 0 0 19
IV 8 0 1 1 1 0 3
V 0 – – – – – –
COHEN I 6 0 0 0 0 0 0
II 15 0 0 0 0 0 0
III 43 0 2 1 0 0 3
IV 49 0 1 1 0 0 2
V 10 0 0 0 0 0 0
Table 1
Distribution of the re-
curring vesicoureteral
reflux after treatment
at 6 months, accord-
ing to its initial
grade.
Patients with Scin (n = 56) Cohen (n = 74)
Without reflux With recurrent reflux Without reflux With recurrent reflux
n = 26 n = 30 n = 69 n = 5
Bacteriuria 4 6 7 1
Pyelonephritis 0 5 8 1
Table 2
Repartition of pa-
tients with bacteriuria
or pyelonephritis ei-
ther with or without
recurrent reflux after
endoscopic sub -
ureteral collagen 
injection (SCIN) or
Cohen reimplantation
 surgery.
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function that remained unchanged, whereas 13 of
24 kidneys submitted to Cohen had an initially
decreased function that normalized in 8 at follow-
up. In children operated after 1 year of age, AI re-
mained unchanged in the SCIN group (at diagno-
sis: 10.2±1.8 %ID, at follow-up: 10.8±2.8 %ID).
In the Cohen group, AI increased from 8.5±3.5%
ID to 10.4±3.7 %ID.
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Discussion
In this study the medium and long-term out-
come following the treatment of VUR by endo-
scopic collagen injection (SCIN) is evaluated and
compared to that after ureteral reimplantation
surgery. In particular the reflux recurrence rate,
the appearance of postoperative UTI and the
 dynamics of renal function were analyzed. This
paper is based on a retrospective analysis. High
grade reflux, impaired renal function and break-
through infection were indications per se to per-
form open reflux surgery. However, in patients
with reflux grade III without impaired function
and infection, collagen injection was preferably
used. Therefore no randomization of the patients
regarding collagen injection and open surgery
could be performed and statistical comparison was
limited.
In our experience the recurrence rate of reflux
after endoscopic injection was comparable to
those reported in the literature. In our series 
an overall absence of reflux was found in 64% 6
months after the first injection. Over an average
observation period of 50 months (12–104 months)
the absence of reflux after one or two injections
increased to 71%. In addition in 21% of ureters
an improvement to reflux grade I or II was pres-
ent, requiring no further treatment. Capozza et al.
[19], who followed a larger cohort with 953
ureters in 679 patients, reported a over-all cure
rate of reflux of 72% ureters following one or two
injections after one year. Another study, where
only collagen was used as injection material
showed similar results [20], with 74% of refluxing
ureters cured by SCIN. In 1995 Frey et al. [16] re-
ported absence of reflux in 63%, after one and in
80% after two injections. Laeckgren et al. [21]
using dextranomer/hyaluronic acid as injectable
material reported comparable findings describing
absence of reflux after 1 or 2 injections in 67%. In
our study 36% of ureters showed recurrent reflux
after one injection at 6 months, however, only
20% needed a second injection, where  reflux was
of persistent high grade (III–IV) or recurrent UTI
of the upper tract was occurring. In accordance
with other authors [22], we believe that even if re-
flux recurrence appears at a later state, the kidney
is protected during the reflux-free period, in par-
ticular during early life when renal growth is
 accelerated and infection can be deleterious for
renal function. 
If we compare SCIN and Cohen reimplanta-
tion, the latter is more reliable with 96% of
ureters free of reflux after operation. If reflux re-
curs following both methods of treatment, it is 
in the majority of cases of a lesser grade. The risk
of stenosis of the vesico-ureteral junction after
Cohen reimplantation is small, with only 1.3%
patients affected, however, if present, early surgi-
cal correction or dilatation is mandatory to pre-
serve renal function. Following SCIN, high grade
reflux persisted in only 2% after one or two injec-
tions and Cohen reimplantation could easily be
performed, as SCIN does not cause any alter-
ations of the uretero-vesical junction and in par-
ticular no unwanted scar formation compromising
reflux surgery. Contrary to the Cohen procedure,
SCIN allows easy endoscopic and radiological in-
vestigation of the ureters. Disappearance of reflux
can be radiologically assessed in every patient dur-
ing recovery from anaesthesia and if reflux per-
sists, re-injection can be performed immediately.
VCUG was performed at 6 months to evaluate
 efficacy of the treatment and at 12 months post-
operatively to exclude occasionally appearing sec-
ondary reflux. The 12 months VCUG control has
now been omitted after the learning curve was
completed, in order to reduce exposure to radia-
tion.  Antibiotic treatment to prevent infection
after cystoscopy and injection was given for 10
days and thereafter followed by prophylaxis until
VCUG proved the absence of reflux at the 6-
month control.
In our study, UTI was observed in 27% after
SCIN and 23% after Cohen reimplantation. In
addition in 9% of patients treated with SCIN and
in 4% with Cohen procedure we found a dysuria
syndrome. Beetz et al. [23] who followed patients
after open surgical reflux correction reported that
during the first 10-years 28% of the patients pre-
sented with a febrile and 18% with an afebrile
UTI. After SCIN, lower UTI, characterized by
bacteriuria without fever, was more frequently ob-
served (10 of 56 patients, ie. 18%) than after open
surgery (8 of 74 patients ie.11%). Multiple bac-
teriuria were predominantly seen in patients
treated with SCIN. After Cohen reimplantation 9
of 74 patients (12%) had pyelonephritis poten-
tially affecting renal function, compared to 5 of 56
patients (9%) in the SCIN group. A possible ex-
planation for these findings lies in the fact, that
the patients were not randomized as in a prospec-
tive study. Patients with high-grade reflux, de-
creased renal function or recurrent UTI despite
antibiotic prophylaxis were selected for open sur-
gery procedure as first preference. UTI after open
surgery occurred in patients free of reflux whereas
UTI after SCIN occurred in patients with recur-
rent reflux. It might well be that in the reflux-free
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Cohen group infection was caused by relative uri-
nary stasis or occurred in a previously damaged
kidney. 
We are convinced, that active reflux treat-
ment has a place in terms of renal protection and
in preservation or improvement of renal function.
This is supported by the “The International Re-
flux Study in Children” [24], stating that the de-
velopment of pyelonephritis is significantly less
frequent in the anti-reflux surgery group than in
the medical group during 10 years of follow-up. 
In this study, we restricted the descriptive sta-
tistical analysis of the renal function to a sub-
group of children presenting bilateral grade III
reflux. This allowed comparison of patients in
both groups with comparable grade of bilateral
reflux showing a comparable renal development
profile. We observed that the accumulation index
(AI) increased in both groups following treat-
ment. It is known that AI reflects renal matura-
tion during the first year of life and that normal
values in infants aged less than 6 months were
lower than those obtained in older children. In
our study, infants less than 1 year of age showed
an increase of AI in both groups, probably reflect-
ing renal maturation. In older infants, we did not
find any difference between pre- and postopera-
tive AI in the SCIN group. This could be ex-
plained by the fact that these kidneys had normal
function at diagnosis when compared to those
treated with open surgery. In the Cohen group,
the increase of AI of kidneys in children aged
more than 1 year at surgery reflected true renal
function improvement. In 9 children, AI re-
mained unilaterally decreased at follow-up, in 4 of
them the contralateral kidney developed AI over
normal range, indicating compensation [25].
In conclusion, re-implantation surgery re-
mains the golden standard for treatment of high-
grade VUR. Recurrence and complications are
rare. SCIN offers an alternative method of treat-
ment for grade III–IV reflux and for lower 
degrees of contralateral reflux. It is less invasive,
can be performed as day surgery and is therefore
less costly. It can easily be repeated or converted
to open surgery if necessary. Recurrent bacteri-
uria was observed more often after SCIN and
pyelonephritis more often after open surgery. In
patients with grade III reflux, the renal function
seems to be preserved with both techniques.
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